News
TAXIS Pharmaceuticals, a clinical stage company at the forefront of developing therapies to treat multidrug-resistant bacterial infections and combat antimicrobial resistance (AMR), announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback